Synthesis and structure-activity relationship study of antidiabetic penta-O-galloyl-D-glucopyranose and its analogues

Journal of Medicinal Chemistry

Volumn 49, Issue 9, 2006, Pages 2829-2837

  Ren, Yulin ^a   Himmeldirk, Klaus ^a   Chen, Xiaozhuo ^a  

^a OHIO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 6 DEOXY 1,2,3,4 TETRA O GALLOYL ALPHA GLUCOPYRANOSE; 6 DEOXYTETRA O GALLOYL ALPHA GLUCOPYRANOSE; ANTIDIABETIC AGENT; GLUCOPYRANOSIDE; GLUCOSE; INSULIN; INSULIN RECEPTOR; PENTA O GALLOYL GLUCOPYRANOSE; PENTA O GALLOYL GLUCOPYRANOSE DERIVATIVE; TETRA O GALLOYL ALPHA XYLOPYRANOSE; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BIOASSAY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG SYNTHESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT SYSTEM; HYPERGLYCEMIA; MOUSE; NONHUMAN; OBESITY; STRUCTURE ACTIVITY RELATION; WEIGHT GAIN;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; DIABETES MELLITUS; GALLIC ACID; GLUCOSE; HYDROLYZABLE TANNINS; MICE; MOLECULAR STRUCTURE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33646458073     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060087k     Document Type: Article

References (52)

1. Devendra, D.; Liu, E.; Eisenbarth, G. S. Type I diabetes: recent developments. BMJ 2004, 328, 750-754.
2. Kahn, B. B.; Flier, J. S. Obesity and insulin resistance. J. Clin. Invest. 2000, 106, 473-481.
3. Saltiel, A. R.; Kahn, C. R. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 2001, 414, 799-806.
4. Moller, D. E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001, 414, 821-827.
5. Dominiczak, M. H. Metabolic syndrome. Curr. Opin. Lipidol. 2003, 14, 329-332.
6. Issa, B. G.; Hanna, F. W. Insulin resistance, the metabolic syndrome and risk of cardiovascular disease: a complex story. Curr. Opin. Lipidol. 2003, 14, 405-407.
7. Kopelman, P. G. Obesity as a medical problem. Nature 2000, 404, 635-643.
8. Camp, H. S.; Ren, D.; Leff, T. Adipogenesis and fat-cell function in obesity and diabetes. Trends Mol. Med. 2002, 8, 442-447.
9. Etgen, G. J.; Oldham, B. A.; Johnson, W. T.; Broderick, C. L.; Montrose, C. R.; Brozinick, J. T.; Misener, E. A.; Bean, J. S.; Bensch, W. R.; Brooks, D. A.; Shuker, A. J.; Rito, C. J.; McCarthy, J. R.; Ardecky, R. J.; Tyhonas, J. S.; Dana, S. L.; Bilakovics, J. M.; Paterniti, J. R., Jr.; Ogilvie, K. M.; Liu, S.; Kauffman, R. F. A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-[alpha][gamma] agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models. Diabetes 2002, 51, 1083-1087.
10. Rieusset, J.; Touri, F.; Michalik, L.; Escher, P.; Desvergne, B.; Niesor, E.; Wahli, W. A new selective peroxisome proliferators-activated receptor γantagonist with antiobesity and antidiabetic activity. Mol. Endocrinol. 2002, 16, 2628-2644.
11. Rocchi, S.; Pichard, F.; Vamecq, J.; Gelman, L.; Potier, N.; Zeyer, D.; Dubuquoy, L.; Bac, P.; Champy, M. F.; Plunket, K. D.; Leesnitzer, L. M.; Blanchard, S. G.; Desreumaux, P.; Moras, D.; Renaud, J. P.; Auwerx, J. A unique PPAR-γ ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol. Cell 2001, 8, 737-747.
12. Kristensen, C.; Anderson, A. S.; Ostergaard, S.; Hansen, P. H.; Brandt, J. Functional reconstitution of insulin receptor binding site from non-binding receptor fragments. J. Biol. Chem. 2002, 277, 18340-18345.
13. Whittaker, J.; Sorensen, H.; Gadsboll, V. L.; Hinrichsen, J. Comparison of the functional insulin binding epitopes of the A and B isoforms of the insulin receptor. J. Biol. Chem. 2002, 277, 47380-47384.
14. Ottensmeyer, F. P.; Beniac, D. R.; Luo, R. Z.-T.; Yip, C. C. Mechanism of transmembrane signaling: insulin binding and the insulin receptor. Biochemistry 2000, 39, 12103-12112.
15. Saltiel, A. R.; Pessin, J. E. Insulin signaling pathways in time and space. Trends Cell Biol 2002, 12, 65-71.
16. Zhang, B.; Moller, D. E. New approaches in the treatment of type 2 diabetes. Curr. Opin. Chem. Biol. 2000, 4, 461-467.
17. Strowski, M. Z.; Li, Z.; Szalkowski, D.; Shen, X.; Guan, X.; Jüttner, S.; Moller, D. E.; Zhang, B. Small-molecule insulin mimetic reduces hyperglycemia and obesity in a nongenetic mouse model of type 2 diabetes. Endocrinology 2004, 145, 5259-5268.
18. Zhang, B.; Salituro, G.; Szalkowski, D.; Li, Z.; Zhang, Y.; Royo, I.; Vilella, D.; Diez, M. T.; Pelaez, F.; Ruby, C.; Kendall, R. L.; Mao, X.; Griffin, P.; Calaycay, J.; Zierath, J. R.; Heck, J. V.; Smith, R. G.; Moller, D. E. Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science 1999, 284, 974-977.
19. Zamanini, A.; Newson, R. B.; Maisey, M.; Feher, M. D. Injection related anxiety in insulin treated diabetes. Diabetes Res. Clin. Pract. 1999, 46, 239-246.
20. Amiel, S. A.; Alberti, K. G. Inhaled insulin. BMJ 2004, 328, 1215-1216.
21. Wigley, F. M.; Londono, J. H.; Wood, S. H.; Shipp, J. C.; Waldman, R. H. Insulin across respiratory mucosae by aerosol delivery. Diabetes 1991, 20, 552-557.
22. Liu, F.; Kim, J.; Li, Y.; Liu, X.; Li, J.; Chen, X. An extract of Lagerstroemia speciosa L has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J. Nutr. 2001, 131, 2242-2247.
23. Kakuda, T.; Sakane, I.; Takihara, T.; Ozaki, Y.; Takeuchi, H.; Kuroyanagi, M. Hypoglycemic effect of extracts from Lagerstroemia speciosa L. leaves in genetically diabetic KK-AY mice. Biosci. Biotechnol. Biochem. 1996, 60, 204-208.
24. Suzuki, Y.; Unno, T.; Ushitani, M.; Hayashi, K.; Kakuda, T. Antiobesity activity of extracts from Lagerstroemia speciosa L. leaves on female KK-AY mice. J. Nutr. Sci. Vitaminol. 1999, 45, 791-795.
25. Liu, X. Q.; Kim, J. K.; Li, Y. S.; Li, J.; Liu, F.; Chen, X. Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells. J. Nutr. 2005, 135, 165-171.
26. Hayashi, T.; Maruyama, H.; Kasai, R.; Hattori, K.; Takasuga, S.; Hazeki, O.; Yamasaki, K.; Tanaka, T. Ellagitannins from lagerstroemia speciosa as activators of glucose transport in fat cells. Planta Med. 2002, 68, 173-175.
27. Okuda, T.; Yoshida, T.; Hatano, T. Hydrolyzable tannins and related polyphenols. Fortschr. Chem. Org. Naturst. 1995, 66, 1-117.
28. Hagerman, A. E.; Carlson, D. M. Biological responses to dietary tannins and other polyphenols. Recent Res. Dev. Agric. Food Chem. 1998, 2, 689-704.
29. Hagerman, A. E.; Riedl, K. M.; Jones, J. A.; Sovik, K. N.; Ritchard, N. T.; Hartzfeld, P. W.; Riechel, T. L. High molecular weight plant polyphenolics (tannins) as biological antioxidants. J. Agric. Food Chem. 1998, 46, 1887-1892.
30. Oh, G. S.; Pae, H. O.; Oh, H.; Hong, S. G.; Kim, I. K.; Chai, K. Y.; Yun, Y. G.; Kwon, T. O.; Chung, H. T. In vitro anti-proliferative effect of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose on human hepatocellular carcinoma cell line, SK-HEP-1 cells. Cancer Lett. 2001, 74, 17-24.
31. Cowan, M. M. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 1999, 12, 564-582.
32. Gin, H.; Rigalleau, V.; Caubet, O.; Masquelier, J.; Aubertin, J. Effects of red wine, tannic acid, or ethanol on glucose tolerance in non-insulin-dependent diabetic patients and on starch digestibility in vitro. Metabolism 1999, 48, 1179-1183.
33. Corder, R.; Douthwaite, J. A.; Lees, D. M. Endothelin-1 synthesis reduced by red wine. Nature 2001, 414, 853-854.
34. Satoh, K.; Nagai, F.; Ushiyama, K.; Yasuda, I.; Seto, T.; Kano, I. Inhibition of Na, K,-ATPase by 1,2,3,4,6-penta-O-galloyl-β-D-glucose, a major constitute of both Mountan cortex and Paeoniae radix. Biochem. Pharmacol. 1997, 53, 611-614.
35. Yoshida, T.; Jin, Z. X.; Okuda, T. Taxifolin apioside and davuricin M1, a hydrolysable tannin from Rosa davurica. Photochemistry 1989, 28, 2177-2181.
36. Nishizawa, M.; Yamagishi, T.; Nonaka, G. I.; Nishioka, I.; Ragan, M. A. Gallotannins of the freshwater green Alga spirogyrasp. Phytochemistry 1985, 24, 2411-2413.
37. Kandil, F. E.; El-Sayed, N. H.; Micheal, H. N.; Ishak, M. S.; Mabry, T. J. Gallotannins and flavonoids from Haematoxylon campechianum. Phytochemistry 1996, 42, 1243-1245.
38. Li, Y.; Li, J.; Liu, F.; Liu, X.; Kim, J.; Himmeldirk, K.; Ren, Y.; Wagner, T. E.; Chen, X. Antidiabetic α-PGG stimulates glucose transport by activating insulin receptor-mediated signaling pathway. Biochem. Biophys. Res. Commun. 2005, 336, 430-437.
39. Li, X. C.; Joshi, A. S.; ElSohly, H. N.; Khan, S. I.; Jacob, M. R.; Zhang, Z. Z.; Khan, I. A.; Ferreira, D.; Walker, L. A.; Broedel, S. E.; Raulli, R. E.; Cihlar, R. L. Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies. J. Nat. Prod. 2002, 65, 1909-1914.
40. Kashiwada, K. Antitumor agents, 129. Tannins and related compounds as selective cytotoxic agents. J. Nat. Prod. 1992, 55, 1033-1043.
41. Feldman, K. S.; Sahasrabudhe, K.; Smith, R. S.; Scheuchenzuber, W. J. Immunostimulation by plant polyphenols: a relationship between tumor necrosis factor-α production and tannin structure. Bioorg. Med. Chem. Lett. 1999, 9, 985-990.
42. Takechi, M.; Tanaka, Y.; Takehara, M.; Nonaka, G. I.; Nishioka, I. Structure and antiherpetic activity among the tannins. Phytochemistry 1985, 24, 2245-2250.
43. Yokozava, T.; Chen, C. P.; Dong, E.; Tanaka, T.; Nonaka, G. I.; Nishioka, I. Study on the inhibitory effect of tannins and flavonoids against the 1,1-diphenyl-2-picrylhydrazyl radical. Biochem. Pharmcol. 1998, 56, 213-222.
44. Khanbabaee, K.; Lotzerich, K. Efficient total synthesis of the natural products 2,3,4,6-tetra-O-galloyl-D-glucopyranose, 1,2,3,4,6-penta-O-galloyl- β-D-glucopyranose and the unnatural 1,2.3,4,6-penta-O-galloyl-α-D- glucopyranose. Tetrahedron 1997, 53, 10725-10732.
45. Neises, S.; Steglich, W. Simple method for the esterification of carboxylic acids. Angew. Chem., Int. Ed. Engl. 1978, 17, 522-524.
46. Feldman, K. S.; Sambandam, A.; Lemon, S. T.; Nicewonger, R. B.; Long, G. S.; Battaglia, D. F.; Ensel, S. M.; Laci, M. A. Binding affinities of gallotannin analogs with bovine serum albumin: ramifications for polyphenol-protein molecular recognition. Phytochemistry 1999, 51, 867-872.
47. Whistler, R. L.; Doner, L. W.; Kosik, M. 1,2,3,4-Tetra-O-acetyl-β-D- glucopyranose and Methyl 2,3,4-Tri-O-acetyl-β-D-glucopyranoside. In Methods in Carbohydrate Chemistry; Whistler. R. L., BeMiller, J. N., Eds.; Academic Press: New York, 1972; Vol. VI. pp 411-412.
48. Evans, M. E.; Parrish, F. W. 6-Cloro-6-deoxy-α-D-glucose. In Methods in Carbohydrate Chemistry, Whistler, R. L., BeMiller, J. N., Eds.; Academic Press: New York, 1972; Vol. VI, pp 193-196.
49. Sakoda, H.; Ogihara, T.; Anai, M.; Makoto, F.; Inukai, K.; Katagiri, H.; Fukushima, Y.; Onishi, Y.; Ono, H.; Yazaki, Y.; Kikuchi, M.; Oka, Y.; Asano, T. No correlation of plasma cell overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes 1999, 48, 1365-1371.
50. Herreros, G. A.; Birnbaum, M. J. The acquisition of increased insulin-responsive hexose transport in 3T3-L1 adipocytes correlates with expression of novel transporter gene. J. Biol. Chem. 1989, 264, 19994-19999.
51. Clinton, R. O.; Geissman, T. A. Gallaldehyde tribenzyl ether. J. Org. Chem. 1943, 65, 85-87.
52. Schmidt, O. T.; Schach, A. Natural tannins. VIII. Synthesis of 3-galloylglucose, 6-galloylglucose and 3,6-digalloylglucose. Liebigs Ann. Chem. 1951, 571, 29-41.